Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study [Corrigendum]

Juya F, Sannes AC, Solli KK, Weimand B, Gjerstad J, Tanum L, Mordal J. J Pain Res. 2025;18:827–836. The authors have advised the affiliation list on page 827 is incorrect. The correct author list and affiliations are as follows. Farid Juya,1,2 Ann Christin Sannes,3,4 Kristin Klemmetsby Solli,1,3,5 Bente Weimand,3,5 Johannes Gjerstad,3,6 Lars Tanum,3,4 Jon Mordal1 1Division of Mental Health and Addiction, Vestfold Hospital Trust, Tønsberg, Norway; 2Faculty of Medicine, University of Oslo, Oslo, Norway; 3Mental Health Services, Akershus University Hospital, Lørenskog, Norway; 4Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway; 5Centre for Mental Health and Substance Abuse, University of South-Eastern Norway, Drammen, Norway; 6School of Health Sciences, Kristiania University College, Oslo, Norway The authors apologize for this error.